Selective tumor targeting by the hypoxia-activated prodrug AQ4N blocks tumor growth and metastasis in preclinical models of pancreatic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17404106

Clin. Cancer Res. 2007 Apr 1 13 7 2216-25

Download in:

View as

General Info

PMID
17404106